BC Gold-Copper Developer Secures US$100M Facility for KSM
Source: Streetwise Reports 08/31/2026
Seabridge Gold secured a US$100 million credit facility to advance its large KSM gold-copper project in British Columbia while pursuing a joint venture. See analyst targets and latest funding details.
Seabridge Gold Inc. (SEA:TSX; SA:NYSE) secured a US$100 million unsecured credit facility in July to fund work at its flagship KSM gold-copper project in British Columbia.
The company closed at CA$45.86 on Monday, August 24, marking a 10.5% gain from the prior Friday close of CA$41.51.
Why the Facility Matters for Retail Investors
The facility gives Seabridge immediate capital to continue feasibility-level work without an immediate equity raise that would dilute existing shareholders. Minimum draws start at US$10 million, interest accrues at 7% compounded monthly, and the facility matures on December 31, 2026, with repayment possible in cash or shares subject to conditions.
Company Position and Project Scale
KSM ranks among the world’s largest undeveloped gold-copper assets and already holds valid provincial and federal environmental certificates.
The project is permitted for construction and scoped for more than 1.0 million ounces of gold per year, plus by-products over a multi-decade mine life.
Key Assets and Next Catalysts
In July, the developer secured the facility while advancing geotechnical, metallurgical, geochemical, and environmental programs across five camps. The UTCAR project stands 40% complete, TCT construction is expected to finish in the fourth quarter of 2026, and the feasibility study remains targeted for the second half of 2027.
Management continues to pursue a formal earn-in joint venture with its preferred partner. The short-maturity facility and strategic lender may signal that a transaction announcement could come before year-end.
Broader Market Timing and Gold Price Drivers
Gold prices have moved with shifting expectations around Federal Reserve policy. A weaker U.S. dollar and lower rate expectations generally support gold, while hawkish signals can pressure the metal and related equities.
Seabridge shares traded within a 52-week range of CA$21.15 to CA$50.77 during this period.
Analyst Views and Valuation Context
Cantor Fitzgerald analyst Mike Kozak rates the stock Buy with a CA$66 target.
RBC Capital Markets analyst Josh Wolfson holds an Outperform rating and US$71 target.
B. Riley Securities analyst Soundarya Iyer maintains a Buy rating with a US$40 target.
Stonegate Capital Partners analyst Dave Storms used an EV/NAV multiple range of 0.8x to 0.9x to arrive at a valuation midpoint of US$68.17 and an EV/In-Situ multiple range of 6.0x to 8.0x to reach US$72.28. [OWNERSHIP_CHART-700]
Share Structure and Ownership1
Management and insiders hold approximately 2% of the company, while institutions own about 59%. The remainder is held by retail investors. There are around 107.87 million shares outstanding and a market cap of CA$5.1 billion.
Key Investor Takeaways
- Seabridge obtained a US$100 million facility that supports KSM advancement without immediate equity dilution.
- KSM remains one of the largest permitted undeveloped gold-copper projects globally with a multi-decade production profile.
- Feasibility study completion is targeted for the second half of 2027, and joint-venture discussions continue.
- Analyst price targets range from US$40 to US$71, all above recent trading levels.
- Gold equities remain sensitive to Federal Reserve policy signals on inflation and rates.
- Regulatory consultation requirements were upheld, but environmental certificates remain valid for the project’s life.
Common Questions from Investors
What is the purpose of the US$100 million facility? The facility funds ongoing feasibility work at KSM and provides flexibility while Seabridge seeks a joint-venture partner.
How large is the KSM resource and production potential? KSM is scoped to produce more than 1.0 million ounces of gold per year, plus by-products over many decades.
Have regulatory issues affected the project timeline? The British Columbia Supreme Court upheld the substantially started designation but ordered further consultation; environmental certificates remain valid.
What are the current analyst targets? Targets include CA$66 from Cantor Fitzgerald, US$71 from RBC Capital Markets, and US$40 from B. Riley Securities.
Will gold prices affect near-term share performance? Gold equities can move with changes in rate expectations, but Seabridge frames KSM value creation around project milestones and partnership progress.
Sign up for our FREE newsletter at: www.streetwisereports.com/get-news
Important Disclosures:
- Seabridge Gold Inc. is a billboard sponsor of Streetwise Reports. The company pays a monthly sponsorship fee of US$3,000–US$6,000 for banner advertising and an enhanced company profile page. Streetwise Reports’ editorial content is fully independent and is not influenced by sponsorship.
- As of the date of this article, officers, contractors, shareholders, and/or employees of Streetwise Reports LLC (including members of their household) own securities of Seabridge Gold Inc.
- Jordan Nova wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
1. Ownership and Share Structure Information
The information listed above was updated on the date this article was published and was compiled from information from the company and various other data providers.
( Companies Mentioned: SEA:TSX; SA:NYSE, )
Source: https://www.streetwisereports.com/article/2026/08/28/bc-gold-copper-developer-secures-us-100m-facility-for-ksm-1.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

